Quick Guide Review important safety considerations from prescribing information before talking with your physician
CagriSema (6.60 (1.16 to 37.76)), tirzepatide (2.88 (2.09 to 3.96)), retatrutide (2.53 (1.17 to 5.46)), orforglipron (2.43 (1.25 to 4.74)), semaglutide (2.37 (1.84 to 3.06)), efpeglenatide (2.32 (1.21 to 4.43)), dulaglutide (2.08 (1.62 to 2.66)), liraglutide (1.99 (1.56 to 2.56)), and exenatide (1.43 (1.03 to 1.99)) were positively associated with diarrhoea compared with placebo (fig 8B)
studied for cravings, little proven effect [8] Guarana: included for energy
& 1993, undefined
semaglutide, a GLP-1 medication meant to sustain the fullness signal over time
Meanwhile, non-peptide alternatives are also making progress